BiotechTube
Home/MannKind/Christine Ocampo
CO

Christine Ocampo

Chief Accounting Officer

MannKind

Therapeutic Areas

Cardiometabolic DiseasesOrphan Lung Diseases

MannKind Pipeline

DrugIndicationPhase
AfrezzaType 1 Diabetes (Pediatric, Newly Diagnosed)Phase 4
FUROSCIX ReadyFlow AutoinjectorFluid OverloadDevelopment
Technosphere Platform (New Formulations)UndisclosedDiscovery/Preclinical

Leadership Team at MannKind

MC
Michael Castagna
Chief Executive Officer
CN
Chris Naftzger
Chief Financial Officer
SB
Steven B. Binder
President & Chief Operating Officer
DT
David Thomson
Chief Scientific Officer
JO
James O. Robbins
Chairman of the Board
View full MannKind profile